Addition of Dornase to Intrapleural Fibrinolytic Therapy Is Not Superior to Fibrinolytic Therapy Alone for Otherwise Healthy Children Hospitalized With Empyema

JAMA Pediatr. 2020 Apr 1;174(4):323-324. doi: 10.1001/jamapediatrics.2019.5910.

Authors

Jonathan Kohler¹, Michelle M Kelly²

Affiliations

¹ Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison.
² Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison.

PMID: 32011656
DOI: 10.1001/jamapediatrics.2019.5910

No abstract available

Publication types

Comment

MeSH terms

Child
Deoxyribonuclease I / therapeutic use
Empyema, Pleural* / drug therapy
Humans
Recombinant Proteins
Thrombolytic Therapy
Tissue Plasminogen Activator* / therapeutic use

Substances

Recombinant Proteins
Deoxyribonuclease I
dornase alfa
Tissue Plasminogen Activator